220 likes | 454 Views
Atrial Fibrillation. Current Management Strategies. Overview. 25% will develop AF during lifetime 4% above 60 8% above 80 Total sufferers to double by 2050 Doubles annual risk of death (Framingham) 5% annual risk of stroke. Definitions. Paroxysmal AF Under 7 days 2 or more episodes
E N D
Atrial Fibrillation Current Management Strategies
Overview • 25% will develop AF during lifetime • 4% above 60 • 8% above 80 • Total sufferers to double by 2050 • Doubles annual risk of death (Framingham) • 5% annual risk of stroke
Definitions • Paroxysmal AF • Under 7 days • 2 or more episodes • Persistent AF • 7 days to 1 year • Permanent AF • Over 1 year with/without intervention • Accepted for rate control
Pathophysiology Supraventricular ectopic focus with permissive atrial substrate Younger Myocytes in pulmonary veins Drugs and alcohol Metabolic abnormalities Electrolyte abnormalities Sepsis Older LVH/aortic stenosis Atrial ischaemia and IHD Mitral stenosis/incompetence Hypertension Catecholamine drive Sepsis
Two Considerations • Reduce ventricular rate • Cardiovert • Slow • Prevent thromboembolism • Cardiovert • Anticoagulate
Treatment Strategies Paroxysmal Persistent Permanent Symptoms Persist Rhythm Control Rate Control Failure Rhythm Control Younger First presentation Underlying cause treated Symptomatic Heart Failure Rate Control Older Coronary artery disease Contraindications to cardioversion Previous failure
Rhythm Control – Paroxysmal AF • All need assessment for anticoagulation • May need cardioversion (but aim to avoid) • Pill in pocket may be appropriate (flecanide) • Standard beta-blocker first line (bisoprolol) • If failure: • CAD – Sotalol • LVD – Amiodarone
Rhythm control – Persistent AF Onset < 48 hours Emergency Department Outpatient Management Heparinise Warfarinise Electrical Chemical Failure likely? Flecanide Amiodarone Rate Control Sotalol or Amiodarone
Rate control – Persistent or Permanent • All patients need assessment for anticoagulation • Aim for rate under 100 (may need nothing) • Beta-blocker of calcium channel antagonist • Add digoxin if further control necessary
Thromboembolism • Ineffective atrial contraction • Venous pooling in atrial appendage • Embolism
CHAD2Vasc • Congestive Cardiac Failure • Hypertension • Age > 75 (2) > 65 (1) • Stroke/TIA/DVT/PE (2) • Vascular disease • Diabetes • Female 0 – Low risk 1 – Moderate risk > 2 high risk
European Society of Cardiology High Risk CVA TIA VTE Medium Risk > 75 HTN EF < 35% DM No Risk Warfarin Aspirin
Ablation/MAZE procedure • 1:1000 death • 1:50 complications • 60% success
Case 1 • 40, fit and healthy, normal ET, normal resting ECG • Onset AF@135bpm 24 hours ago, first event • Haemodynamically stable • Bloods normal Anticoagulant? Heparin then Aspirin 75mg Cardioversion? Flecanide 300mg Maintenance? Pill in pocket
Case 2 • 60, on carbimazole and bendroflumethiazide • AF for 24 hours, otherwise normal examination • All bloods normal including TFTs Anticoagulant? Heparin then warfarin Cardioversion? Electrical (not amiodarone) Maintenance? Bisoprolol
Case 3 • 28 fit and well, onset AF 3 hours ago • Mild symptoms, examination normal • Bloods normal Anticoagulant? Heparin then aspirin Cardioversion? Not today, return starved tomorrow Maintenance? Pill in pocket
Case 4 • 89, SOB, tachycardic, febrile, cough • Raised WCC and ARF and hypokalaemia Anticoagulant? Probably Cardioversion? Not until treated Maintenance? Review prior to discharge
Case 5 • 80, hypertensive, smoker with COPD • Incidental finding, symptom free • Rate 110bpm Anticoagulant? Warfarin Cardioversion? No Maintenance? Diltiazem
Case 6 • 50, AF 8 hours, ejection systolic murmur • Bloods normal Anticoagulant? Heparin then aspirin Cardioversion? Amiodarone Maintenance? Bisoprolol
Case 7 • 50, AF 8 hours, ejection systolic murmur • Bloods normal Anticoagulant? Heparin then aspirin Cardioversion? Amiodarone Maintenance? Bisoprolol